Presentation on HER3-DXd, I-DXd, R-DXd Strategic Collaboration

from the beginning

HER3-DXd, I-DXd (DS‐7300), R-DXd (DS-6000)
Strategic Collaboration
with Merck & Co., Inc., Rahway, NJ, USA

Forward-Looking Statements

1. Background/Significance of the Collaboration

Daiichi Sankyo’s Oncology Business Growth Strategy

Environmental Changes since April 2023

Why a Strategic Collaboration?

What We Aim to Achieve through Strategic Collaboration

Why Merck & Co., Inc., Rahway, NJ, USA?

2. Overview of the Collaboration

Strategic Collaboration Overview

Strategic Collaboration Overview

Financial Terms for Strategic Collaboration

Daiichi Sankyo will contribute to the enrichment of quality of life around the world

@

Q&A

• Q&A 1

• Q&A 2

• Q&A 3

• Q&A 4

• Q&A 5

• Q&A 6

• Q&A 7

• Q&A 8

• Q&A 9

• Q&A 10

• Q&A 11

• Q&A 12